Analyte monitoring methods and systems

Information

  • Patent Grant
  • 10330667
  • Patent Number
    10,330,667
  • Date Filed
    Friday, June 24, 2011
    13 years ago
  • Date Issued
    Tuesday, June 25, 2019
    5 years ago
Abstract
A method is disclosed involving monitoring the concentration of at least one target analyte in a sample of body fluid using a meter, the meter including a user interface, the method including: obtaining a sample of body fluid; testing the sample to determine the concentration of the at least one target analyte contained therein; and presenting the user with a reminder to associate the test with an appropriate time corresponding to before or after a particular meal using the user interface. Associated devices, systems and arrangements are also disclosed.
Description
FIELD

The invention described herein relates to methods, devices, arrangements and/or systems for monitoring a target analyte in a simpler, more accurate manner.


BACKGROUND

In this specification where a document, act or item of knowledge is referred to or discussed, this reference or discussion is not an admission that the document, act or item of knowledge or any combination thereof was at the priority date, publicly available, known to the public, part of common general knowledge, or otherwise constitutes prior art under the applicable statutory provisions; or is known to be relevant to an attempt to solve any problem with which this specification is concerned.


Currently, commercially available glucose monitoring systems typically contain a number of separate components. Namely, separate lancing devices for creating a droplet of blood on the skin, test strips, and a meter configured to receive one test strip at a time. A test strip is inserted into the meter before or after the skin is lanced with the separate lancing device, then the strip is maneuvered into contact with the droplet of blood on the surface of the skin. The strip absorbs the blood, then the blood is analyzed by the strip/meter to determine the concentration of glucose contained therein.


Many of these devices allow people with diabetes to mark an individual glucose measurement to associate the result with a particular meal, or meal-time. For example, the meter might allow a user to, after a result is displayed on the meter, associate that result with “breakfast”. If a user diligently marked their results associating them with the appropriate meal-time, then a user's health care provider may be able to analyze the data looking for trends in measurement that can be used to adjust the delivery time and dosage of any treatments provided (e.g., insulin). In current commercially available devices, this marking procedure must be initiated by the user.


It should be noted that another deficiency of current commercially available meters is that the available marking options are is imprecise. In particular, a person with diabetes will experience rises in glucose levels following the consumption of food. For a health care provider to make appropriate adjustments in treatments, they need to understand if particular results came before or following meals (pre or post-prandial). While there are some devices that allow for marking of results directly on the analyte monitor, it is also quite common to use a paper “logbook” to track individual results. However, it is not sufficient to only associate a particular result with a particular meal. Instead, in order to more accurately interpret and utilize the test results, it should be associated with a time period before or after a particular meal.


Additional problems with current technology include:


patient compliance—many patients find marking meals confusing and simply choose not to mark any meals, or worse, will mark, perhaps without even realizing it, individual results as being associated with a particular meal when in fact the test did not actually occur before or after a meal.


lack of data, or inaccurate data, can lead to less than optimal treatment plans, or even worse risk of harm to the patient if too much or too little treatment (drugs, insulin etc.) are provided.


data accuracy—it is quite easy to make mistakes in marking meals using currently commercially available meters.


the process for marking directly on the device is not intuitive, users must initiate the marking process, which typically involves the need to memorize a long system of key/button presses or a need to consult their users guide for directions.


when using paper and pencil a user can transcribe the result incorrectly, or write the result in the wrong section of the logbook. Also, such information cannot be easily transferred or shared with health care professionals.


marking a test as only generally being associated with a particular meal does not provide fully accurate, useful information.


time—people with diabetes can spend a significant amount of time searching for logbooks, or re-reading instructions to understand how to mark meals.


safety—incomplete or inaccurate data can lead to mistakes in treatment harming patients.


While certain aspects of conventional technologies have been discussed to facilitate disclosure of the invention, Applicants in no way disclaim these technical aspects, and it is contemplated that the claimed invention may encompass or include one or more of the conventional technical aspects discussed herein.


SUMMARY OF THE INVENTION

As used herein, “body fluid” encompasses whole blood, interstitial fluid, and mixtures thereof.


As used herein “integrated device” or “integrated meter” means a device or meter that includes all components necessary to perform sampling of body fluid, transport of body fluid, quantification of an analyte, and display of the amount of analyte contained in the sample of body fluid. Exemplary integrated meters are described in: U.S. Pat. Nos. 6,540,675 and 7,004,928; U.S. Patent Application Publication Nos. US 2008/0077048, US 2007/0179404, US 2007/0083131, US 2007/0179405, US 2007/0078358, and US 2007/0078313. The entire contents of each of the above-listed documents are incorporated herein by reference.


It is to be understood that reference herein to first, second, third and fourth components (etc.) does not limit the present invention to embodiments where each of these components is physically separable from one another. For example, a single physical element of the invention may perform the functions of more than one of the claimed first, second, third or fourth components. Conversely, a plurality of separate physical elements working together may perform the functions of one of the claimed first, second, third or fourth components. Similarly, reference to first, second (etc.) method steps does not limit the invention to only separate steps. According to the invention, a single method step may satisfy multiple steps described herein. Conversely, a plurality of method steps could, in combination, constitute a single method step recited herein. In addition, the steps of the method are not necessarily limited to the order in which they are described or claimed herein.


The present invention may address one or more of the problems and deficiencies of the prior art discussed above. However, it is contemplated that the invention may prove useful in addressing other problems and deficiencies, or provide benefits and advantages, in a number of technical areas. Therefore the claimed invention should not necessarily be construed as being limited to addressing any of the particular problems or deficiencies discussed herein.


The invention can be useful with any device, but is particularly applicable to analyte monitors used in a home or clinical setting such as glucose monitors. This invention is advantageous when used in conjunction with a fully integrated glucose meter. However, the invention is not so limited. The benefits and advantages of the invention can also be applied to other devices such as conventional (non-integrated) glucose meters and other self-diagnostic devices where collection of long term data and analysis of trends in data is important.


The present invention can provide one or more of the following benefits and advantages relative to current technology:


convenience of never having to look for instructions or paper log books, and the meter initiates the marking procedure, not the user. For example, according to the present invention, the results of the test can be displayed along with a reminder to mark the test as before or after a particular meal.


“screen real-estate”—size is a key factor for patients choosing a handheld analyte monitor and many of the LCD's used in these devices are created with fixed segments that are turned on or off to display relevant information. By compactly displaying all possible meal markers this invention saves space on the screen, which in turn allows for more of the screen used for other purposes and can therefore help reduce the overall size of the device.


significant increase in caregiver's confidence in data collected by the meter.


significant increase in the amount of accurate and useful data collected by user (pre and post prandial data).


improved ability to monitor/detect trends in test results.


ability to confidently adjust patient medications based on data collected by meter.


allows the meter to internally process data not available to currently used glucose monitors (e.g., a 7-day pre and/or post-meal average calculated by the meter).


accurate on-device averages of pre/post prandial results.


data once calculated by the device can easily be exported by the data management software used by healthcare professionals to pull data from patients' devices.


time/cost savings—by having the data automatically and accurately exported healthcare professionals are able to assist patients more quickly.


can provide users with information not available on conventional glucose meters.


According to one aspect, the present invention provides a method of monitoring the concentration of at least one target analyte in a sample of body fluid using a meter, the meter comprising a user interface, the method comprising:


obtaining a sample of body fluid; testing the sample to determine the concentration of the at least one target analyte contained therein; and presenting the user with a reminder to associate the test with an appropriate time corresponding to before or after a particular meal using the user interface.


According to a further aspect, the present invention provides a testing device comprising: a user interface, a processor and a memory, the device constructed an arranged to provide the results of a test and substantially simultaneously provide the user with a reminder to associate the results of the test with an appropriate time before or after a particular meal, and to store the associated results in the memory.





BRIEF DESCRIPTION OF THE DRAWING FIGURES

The following description of preferred embodiments can be read in connection with the accompanying drawings in which like numerals designate like elements and in which:



FIG. 1 is a schematic plan view of certain embodiments of the present invention.



FIG. 2 is a partial plan view of certain alternative embodiments of the present invention.



FIG. 3 is an exemplary icon used in connection with certain aspects of the present invention, designating a first marked testing time (pre-breakfast).



FIG. 4 is the icon of FIG. 3, designating a second marked testing time (post-breakfast).



FIG. 5 is an illustration of a method or technique of the present invention, optionally Used in conjunction with the device of FIG. 2.





DETAILED DESCRIPTION

It should be emphasized that the devices and methods described are intended to apply to any number of devices, meters or monitors. Thus, while according to certain embodiments, the principles of the present invention are applied to and used in conjunction with an integrated meter, the present invention is also usable with other devices such as conventional (non-integrated) analyte monitors. How the analyte measurement result is acquired by a particular device is not critical to implementation or practice of the present invention. The present invention is more relevant to what the device can do with results once collected. Thus, unless specifically stated to the contrary, the following description should be read as being applicable to any device, such as conventional non-integrated monitoring devices and systems, as well as integrated glucose monitors or meters. For example, when images of a display are shown or described the display could be that of any suitable device, such as a stand alone, test-strip-based device or a semi or fully integrated device. Also, the icons disclosed herein are associated with exemplary embodiments and may be changed, and still fall within the scope of the invention.


The invention provides, inter alia, an elegant and simple user interface that allows users of an analyte monitor to quickly and accurately associate a particular measurement as either pre or post-meal (pre/post-prandial).


One aspect of the invention is the functionality of a user interface that displays all possible meal time markings on a single portion of the display. Specifically, according to certain embodiments, all 6 possible meal markings are shown on the screen at one time (before or after each of breakfast, lunch, and dinner), with only one appropriate meal marker time ultimately selected. Users of the device can optionally cycle through all possible markings by interaction with an a user interface, for example, by pressing a simple up or down arrow on the side of the device or by utilizing a touch screen-type interface. Once the particular meal marker is suggested users can confirm their selection, also through interaction with the user interface, such as by pressing the power button which simultaneously marks a result and places the device into sleep mode, and/or by utilizing a touch screen-type interface.


Other aspects of the present invention involves methods or techniques for monitoring the concentration of at least one target analyte contained in a sample of body fluid. Any suitable target analyte may be monitored, such as glucose, hemoglobin, bilirubin, etc., or combinations thereof. Moreover, any suitable body fluid may be analyzed, such as saliva, urine, blood, interstitial fluid, or mixtures thereof.


As an initial step, a sample of body fluid is collected. Any suitable technique for the collection of body fluid is contemplated. For example, when the body fluid to be analyzed comprises blood, a sample can be obtained in a number of different ways. When the principles of the present invention are applied in the context of blood glucose monitoring, a sample of blood can be obtained, for example, by lancing a surface of the skin, thereby creating a wound from which a sample of blood can be obtained. Any suitable instrument can be used to create the wound, such as a solid lancet or hollow needle.


Subsequently, or concurrently, the sample is optionally transported to an appropriate analysis site, and analyzed to determine the concentration of the at least one target analyte contained therein. Any suitable technique for determining the concentration can be utilized. For example, when the principles of the present invention are utilized in the context of blood glucose monitoring, conventional electrochemical or colorimetric techniques can be utilized to ascertain the concentration of glucose contained in the sample of body fluid or blood. The results of the analysis are then presented to the user or tester. The results can be presented in any suitable manner, such as by visually displaying the results, and/or by audibly communicating the results.


According to the present invention, the user is also presented with a reminder to associate the results of the test with an appropriate time corresponding to before or after a particular meal. According to one alternative embodiment, this reminder is presented at approximately the same time as the results of the test are presented to the user. However, it should be recognized that this reminder can be provided at any suitable time so long as the user is reminded in adequate time to mark the results of the test in the desired fashion. This reminder can be presented to the user in any suitable manner. For instance, the reminder may be visually presented on a display, and/or by audibly communicating a reminder. When the reminder is visually presented on a display, any suitable symbol or combination of symbols can be utilized to communicate to the user that they should associate the test results with an appropriate time before or after a particular meal. According to one optional embodiment, an icon is displayed which contains a combination of symbols representative of all desired possible marking times. According to a further optional embodiment, an icon is displayed comprising symbols corresponding to breakfast (e.g., rising sun), lunch (e.g., midday sun), and dinner (e.g., moon), and the icon further comprises a selectable portion which can be selectively associated with an appropriate time before or after one of the above-mentioned meals. The selectable portion of the icon can be associated with an appropriate time by any suitable manner. Thus, according to certain optional embodiments, the selectable portion can be located appropriately by use of an interface device, such as one or more buttons, touch pads, touch screen, joysticks, and the like. Optionally, the selectable portion of the icon can be associated by using voice or audible commands in conjunction with voice/audible command recognition capabilities.


Further alternative embodiments include suggesting to the user an appropriate marking time for the just-completed test, based upon the time of day at which the test has been taken. For example, if the user completes a test at 6:30 AM it may be automatically suggested to the user that the test be marked as pre-breakfast. The automatic suggestion is again based upon the time of day, and optionally upon additional input which is preprogrammed and/or provided by the user. Thus, a device or mechanism can be provided which is preprogrammed to suggest that any test performed at 6:30 AM or earlier be suggested for marking as a pre-breakfast test. Alternatively, or in addition thereto, the user may customize this suggestion. For example, the user can specify that any test performed prior to 7 AM be suggested for marking as a pre-breakfast testing event.


Once the results of a particular test have been associated with an appropriate time before or after a particular meal, both the results of the test and the specified time association information is stored in any suitable manner using any suitable media. For example, the information can be stored as binary information in a memory device. According to certain embodiments, the information is stored in a format that is easily retrieved, shared and analyzed.


Further aspects of the present invention involves devices, systems, arrangements and the like which embody any or all of the above-mentioned functionality. Illustrative embodiments of such devices, systems and arrangements are described herein in connection with reference to FIGS. 1-5.



FIG. 1 illustrates an exemplary device 10. The device 10 is capable of determining the concentration of at least one target analyte contained in a sample of body fluid. Any suitable target analyte may be monitored, such as glucose, hemoglobin, bilirubin, etc., or combinations thereof. Moreover, any suitable body fluid may be analyzed, such as saliva, urine, blood, interstitial fluid, or mixtures thereof. As previously mentioned herein, such devices 10 can take a number of different forms. Thus, the device 10 can comprise an analyte monitor or meter that is designed to be used in conjunction with non-integrated systems. Thus, for example, the device 10 can be configured to cooperate with one or more of a separate test strip(s) and/or separate body fluid production/collection device(s). When configured in this manner, the device 10 can optionally include a slot or opening 11 which is configured to receive a separate test strip or cartridge therein, as previously mentioned above. When the device 10 is in the form of an integrated meter or monitor, it includes mechanisms for obtaining a sample of body fluid, analyzing the sample of body fluid, and presenting the results of the analysis, all within a single self-contained unit. Suitable integrated devices are mentioned herein, and the specifics of such constructions and modes of operation are described in the documents incorporated by reference herein.


The illustrated device 10 may include a suitable user interface 12. Alternatively, the interface can be provided separate from the device 10. For example, the device 10 may include all features necessary for analyzing a sample to determine the concentration of a target analyte contained therein, and be connected with a wired or wireless connection to a separate or remote interface, such as a display. The user interface 12 can include a display 14. Any suitable display is contemplated. According to one optional embodiment, the display 14 comprises an LCD. The user interface 12 may additionally include further components or features for interacting with a user. Thus, the user interface 12 may optionally include an audible input/output device 15, which may be in the form of a speaker and/or microphone. Additional components or features of the user interface 12 may optionally include input devices such as one or more of: buttons 16, touch pad 17, joystick 18, or any combination thereof. According to another optional construction encompassed by the above-described interface and display, the display 14 may also comprise a touch screen-type interface. According to further alternative aspects, the user interface 12 of the device 10 can include audible/voice recognition capabilities. For example, a user can interact with the device 10 by speaking or providing audible input via the audible input/output device 15, which are then interpreted and converted by the device into executable commands.


The device 10 may further be provided with a memory component 20 and a processor 22, which are operatively interconnected. Such components can be used according to generally known techniques to control the storage, manipulation and/or retrieval of information, as well as controlling, and responding to, the various components of the user interface 12.


The device 10 may include one or more sample transport features and/or analysis site comprising mechanisms for determining the concentration of at least one target analyte contained in the sample. For example, when the principles of the present invention are utilized in the context of blood glucose monitoring, conventional electrochemical or colorimetric mechanism can be included in the device 10 to ascertain the concentration of glucose contained in the sample of body fluid or blood. Examples of such mechanisms are described in greater detail in the documents incorporated herein by reference, and as previously pointed out, are not critical to practice the concepts of the present invention. The device 10 then presents the results of the analysis to the user. The results can be presented in any suitable manner, such as by visually displaying the results 24 on the display 14, and/or by audibly communicating the results via the audible input/output device 15.


According to the present invention, the device 10 also presents the user with a reminder to associate the results of the test with an appropriate time corresponding to before or after a particular meal. According to one alternative embodiment, this reminder is presented at approximately the same time as the results of the test are presented to the user. However, it should be recognized that this reminder can be provided at any suitable time so long as the user is reminded in adequate time to mark the results of the test in the desired fashion. This reminder can be presented to the user in any suitable manner. For instance, the reminder 26 may be visually presented on the display 14, and/or by audibly communicating a reminder via the audible input/output device 15. When the reminder 26 is visually presented on a display 14, any suitable symbol or combination of symbols can be utilized to communicate to the user that they should associate the test results with an appropriate time before or after a particular meal. According to one optional embodiment, the reminder 26 comprises an icon that is displayed which contains a combination of symbols representative of all desired possible marking times. According to a further optional embodiment, the reminder 26 comprises an icon is having symbols corresponding to breakfast (e.g., rising sun), lunch (e.g., midday sun), and dinner (e.g., moon), and the icon further comprises a selectable portion (e.g., 26′, FIGS. 2-5) which can be selectively associated with an appropriate time for or after one of the above-mentioned meals. The selectable portion of the icon can be associated with an appropriate time by any suitable manner. Thus, according to certain optional embodiment, the selectable portion can be located appropriately by use of an interface device, such as one or more buttons 16, touch pads 17, touch screens 14, joysticks 18, and the like. Optionally, the selectable portion of the icon can be associated by using voice or audible commands via audible input/output device 15, in conjunction with voice/audible recognition capabilities possessed by the device 10.


The device 10 may further include the capability to suggest to the user an appropriate marking time for the just-completed test, based upon the time of day at which the test has been taken. For example, the device 10 is provided with a clock 28. The clock 28 can be manually set by the user, or may be automatically set and/or adjusted by any suitable mechanism. Such a device incorporating an automatic clock is disclosed in US 2010-0021948, the entire contents of which is incorporated herein by reference. In either case, if the user completes a test at 6:30 AM, the device 10 may suggest to the user via the user interface 12, in any manner described herein, to mark the test as pre-breakfast. The automatic suggestion is again based upon the time of day, and optionally upon additional input which is preprogrammed or provided by the user. Thus, the device 10 can be preprogrammed (e.g., factory programmed) to suggest that any test performed at 6:30 AM or earlier be suggested for marking as a pre-breakfast test. Alternatively, or in addition thereto, the user may customize this suggestion. For example, the user can program the device 10 to specify that any test performed prior to 7 AM be suggested for marking as a pre-breakfast testing event.


Once the results of a particular test have been associated with an appropriate time before or after a particular meal, both the results of the test and the specified time association information is stored in any suitable manner using any suitable media, such as the memory 20. For example, the information can be stored as binary information in the memory device 20. According to certain embodiments, the information is stored in a format that is easily retrieved, shared and analyzed.


A device constructed according to further alternative embodiments, and associated methods, are illustrated and described in connection with FIGS. 2-5. It should be understood that this embodiment may include any or all of the previously described functionality and/or features of the previously described embodiments.


The device 10′ illustrated therein can be in the form of an integrated monitor or meter. Thus, it may possess any or all of the features associated with such integrated monitors, and as described in the documents incorporated by reference herein. In addition, the previously described principles of the present invention, when applied to such an integrated device 10′, possesses numerous benefits and advantages, as generally described herein.


As with the previously described embodiments, the device 10′ optionally includes a user interface 12′ associated with the device 10′. The user interface 12′ can include a number of features, such as a display 14′, which may also comprise a touch-screen-type interface, and/or one or more buttons 16′. Upon analysis of a suitable sample of body fluid, the device 10′ analyzes the sample and determines the concentration of at least one target analyte contained therein. These results are then presented to the user. According to the illustrated embodiment, the results 24′ are presented to the user by displaying them on the display 14′. The electronics, and interactions therewith necessary to accomplish this display functionality is generally well-known to those in the art, and is not critical practice the principles of the present invention. In addition, the device 10′ presents a reminder to the user to associate the results 24′ with an appropriate time before or after a particular meal. The device 10′ can present this reminder in any suitable manner. According to the illustrated embodiment, the reminder is presented on the display 14′ in the form of an icon 26′. The icon 26′ can comprise any suitable symbol or combination of symbols to communicate to the user that they should associate the test results with an appropriate time before or after a particular meal. According to the illustrated embodiment, the icon 26′ contains a combination of symbols representative of all desired possible marking times. Further, the illustrated embodiment comprises symbols corresponding to breakfast (e.g., rising sun), lunch (e.g., midday sun), and dinner (e.g., moon), and the icon 26′ further comprises a selectable portion 27 which can be selectively associated with an appropriate time before or after one of the above-mentioned meals. The selectable portion 27 of the icon can be associated with an appropriate time/meal by any suitable manner. Thus, according to certain optional embodiments, the selectable portion 27 can be located appropriately by use of an interface device, such as one or more buttons 16′, or a touch screen 14′. As with the previously described embodiments, the selectable portion 27 can be manipulated with alternative interface devices such as, touch pads, touch screens, joysticks, and audible commands, which may optionally form part of the device 10′.


The device 10′ may optionally further include the previously described features and functionality associated with suggesting an appropriate time marking to the user based upon the time of day at which the test is conducted. The device 10′ may optionally utilize a manually set or automated clock, as previously described.


One possible mode of operation of the device 10′ is illustrated in FIG. 5. The integrated device 10′ is utilized in a known manner to produce and collect a sample of body fluid, transport the sample to an appropriate analysis site within the device 10′, and analyzed a sample to determine the concentration of a target analyte contained therein. Once this analysis has been performed, the results 24′ are presented to the user on the display 14′. According to the illustrated embodiment, a reminder to mark the results as associated with an appropriate time before or after a particular meal is also displayed or presented to the user at substantially the same time as the display of the results 24′. Although it is contemplated that the reminder may be presented at a time which is before or after presentation of the results, as previously noted herein. According to the illustrated embodiment, the reminder is in the form of an icon 26′. The icon 26′ contains a combination of symbols representing breakfast, lunch and dinner. The icon 26′ further includes a selectable portion 27 for associating the results of the test with a time before or after a particular meal. The selectable portion 27 is optionally suggested to the user based at least in part upon the time of day at which the test is conducted as indicated by the clock 28 of the device 10′. According to one alternative, the selectable portion 27 flashes in the suggested location. Regardless of whether an appropriate marking is suggested by the device 10′, the user may change the position of the selected portion by using any suitable interface, such as the buttons 16′ of the device 10′, or by a touch screen 14′. Thus, according to the illustrated embodiment, should the user agree with the suggested marking, the user can make the selection by any suitable means, such as by simply pressing the power button to confirm that this is the appropriate time marking for the testing event. If the user wishes to deviate from the suggested marking position, or independently select an appropriate marking position for the selectable portion 27 of the icon 26′, the user can change the position of the selectable portion 27 by use of one or more of the buttons 16′ of the device 10′, or by utilizing a touch screen 14′. Again, once the user is satisfied with the appropriate positioning of the selectable portion 27, the choice is confirmed (e.g., by pushing the power button), and the procedure is completed. The device 10′ then stores the results along with the associated time information in a memory 20 of the device 10′, which can then be retrieved and analyzed either with by the device itself 10′, or by external devices (not shown).


Numbers expressing quantities of ingredients, constituents, reaction conditions, and so forth used in this specification are to be understood as being modified in all instances by the term “about”. Notwithstanding that the numerical ranges and parameters setting forth, the broad scope of the subject matter presented herein are approximations, the numerical values set forth are indicated as precisely as possible. Any numerical value, however, may inherently contain certain errors necessarily resulting from the standard deviation found in their respective measurement techniques. None of the elements recited in the appended claims should be interpreted as invoking 35 U.S.C. § 112, 116, unless the term “means” is explicitly used.


Although the present invention has been described in connection with preferred embodiments thereof, it will be appreciated by those skilled in the art that additions, deletions, modifications, and substitutions not specifically described may be made without departing from the spirit and scope of the invention as defined in the appended claims.

Claims
  • 1. A method comprising: presenting the user with a reminder to associate an analyte test result with an appropriate time corresponding to before or after a meal using a meter comprising a user interface, wherein presenting the reminder comprises displaying an icon on the user interface, wherein the icon comprises a plurality of symbols and a meal time indicator, wherein each symbol corresponds to a different meal and the meal is either breakfast, lunch, or dinner, and the meal time indicator is moveable between a pre-meal position for each meal and a post-meal position for each meal.
  • 2. The method of claim 1, wherein the meter comprises an integrated meter.
  • 3. The method of claim 1, wherein the user interface comprises a display.
  • 4. The method of claim 3, wherein the user interface comprises a mechanism for presenting an audible signal to the user.
  • 5. The method of claim 1, wherein the method further comprises piercing skin of the user thereby creating a wound, and receiving a sample of body fluid from the wound.
  • 6. The method of claim 5, further comprising transporting the sample of body fluid to an analysis site within the meter.
  • 7. The method of claim 1, wherein presenting the user with a reminder further comprises producing an audible signal.
  • 8. The method of claim 1, wherein the plurality of symbols comprises symbols that correspond to breakfast, lunch, and dinner.
  • 9. The method of claim 1 further comprising: receiving user input regarding a position of the meal time indicator of the icon, thereby associating the analyte test result with an appropriate time corresponding to a time before or after a meal.
  • 10. The method of claim 1, wherein the user interface comprises a display, and the method further comprises displaying the analyte test result, and substantially simultaneously displaying the reminder to associate the analyte test result with an appropriate time corresponding to before or after a meal.
  • 11. The method of claim 1, wherein the meter comprises a clock, and wherein when presenting the user with the reminder, the meter suggests a position of the meal time indicator of the icon based upon the time of day indicated by the clock.
  • 12. The method of claim 11 further comprising receiving confirmation of the suggested position, or receiving instructions to move the meal time indicator to a different position in the icon.
  • 13. The method of claim 9, wherein association thereof associating the analyte test result with an appropriate time corresponding to before or after a meal generates data, and wherein the meter comprises a memory, and the method further comprises storing the data in the memory.
  • 14. The method of claim 13, further comprising exporting the data from the meter.
  • 15. The method of claim 14, further comprising exporting the data to heath care management software.
  • 16. The method of claim 14, further comprising automatically exporting the data from the meter without user intervention.
  • 17. The method of claim 1 further comprising associating the analyte test result with an appropriate time before or after a meal and storing the analyte test result in a memory, wherein the analyte test result is associated with the appropriate time before, after, or concurrently with storing the analyte test result in the memory.
  • 18. The method of claim 17 further comprising receiving instructions to associate a stored analyte test result with the appropriate time via the user interface of the meter.
  • 19. The method of claim 18, wherein the user interface comprises a display and at least one control.
  • 20. The method of claim 19, wherein the at least one control comprises at least one of: a button, a joystick, a touchpad, a touch screen, or a trackball, or combinations thereof.
  • 21. The method of claim 17, wherein the meter automatically associates the analyte test result with the appropriate time before or after a meal.
  • 22. A testing device comprising: a user interface;a non-transitory memory comprising instructions to: provide the user with a reminder via the user interface to associate an analyte test result with an appropriate time before or after a meal, wherein the reminder comprises an icon and the icon comprises a plurality of symbols and a meal time indicator, wherein each symbol corresponds to a different meal and the meal is either breakfast, lunch, or dinner, and the meal time indicator is moveable between a pre-meal position for each meal and a post-meal position for each meal; andstore the associated analyte test result in the memory; anda processor programmed to carry out the instructions on the non-transitory memory.
  • 23. The device of claim 22, wherein the user interface comprises a display.
  • 24. The device of claim 22, wherein the device comprises a mechanism for producing an audible signal to the user.
  • 25. The device of claim 22, wherein the testing device comprises a meter configured to determine a concentration of at least one target analyte contained in a sample of body fluid.
  • 26. The device of claim 25, wherein the analyte comprises glucose and the body fluid comprises blood.
  • 27. The device of claim 26, wherein the meter comprises an integrated meter configured to collect the sample of body fluid from the user, test the sample to determine the concentration of target analyte contained therein, and present the analyte test result to the user, all in a single unitary device.
  • 28. The device of claim 27, the device further comprising an analysis site and a mechanism for transporting the sample of body fluid to the analysis site within the meter.
  • 29. The device of claim 22, wherein the plurality of symbols comprises symbols that correspond to breakfast, lunch, and dinner.
  • 30. The device of claim 22, wherein the user interface comprises a mechanism for selecting or confirming the position of the meal time indicator of the icon to associate the analyte test result with an appropriate time corresponding to a time before or after breakfast, lunch, or dinner.
  • 31. The device of claim 22, wherein the meter comprises a clock, and wherein the non-transitory memory further comprises instructions to, when providing the user with a reminder, suggest an appropriate position of the meal time indicator of the icon based upon the time of day indicated by the clock.
  • 32. The device of claim 30, wherein the mechanism comprises at least one of: a button, a joystick, a touchpad, a touch screen or a trackball, or combinations thereof.
  • 33. The method of claim 8, wherein the symbol that corresponds to breakfast is an image of a rising sun and the symbol that corresponds to dinner is an image of a moon.
  • 34. The method of claim 33, wherein the symbol that corresponds to lunch is an image of a midday sun.
  • 35. The device of claim 29, wherein the symbol that corresponds to breakfast is an image of a rising sun and the symbol that corresponds to dinner is an image of a moon.
  • 36. The device of claim 35, wherein the symbol that corresponds to lunch is an image of a midday sun.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Application No. 61/358,825, filed Jun. 25, 2010.

US Referenced Citations (593)
Number Name Date Kind
842690 Oswalt Jan 1907 A
D137874 Partridge May 1944 S
2749797 Harks Mar 1950 A
3092465 Adams, Jr. Jun 1963 A
3310002 Wilburn Mar 1967 A
3620209 Kravitz Nov 1971 A
3623475 Sanz et al. Nov 1971 A
3626929 Sanz et al. Dec 1971 A
3630957 Rey Dec 1971 A
D223165 Komendat Mar 1972 S
3723064 Liotta Mar 1973 A
3741197 Sanz et al. Jun 1973 A
3961898 Neeley et al. Jun 1976 A
3992158 Przybylowicz et al. Nov 1976 A
4014328 Cluff et al. Mar 1977 A
4042335 Clement Aug 1977 A
4057394 Genshaw Nov 1977 A
4109655 Chacornac Aug 1978 A
4250257 Lee et al. Feb 1981 A
4253083 Imamura Feb 1981 A
4254083 Columbus Mar 1981 A
4258001 Pierce et al. Mar 1981 A
4260257 Neeley et al. Apr 1981 A
4289459 Neeley et al. Sep 1981 A
4321397 Nix et al. Mar 1982 A
4350762 DeLuca et al. Sep 1982 A
4394512 Batz Jul 1983 A
4414975 Ryder et al. Nov 1983 A
4416279 Lindner et al. Nov 1983 A
4418037 Katsuyama et al. Nov 1983 A
4422941 Vaughan, Jr. et al. Dec 1983 A
4429700 Thees et al. Feb 1984 A
4627445 Garcia et al. Dec 1986 A
4637403 Garcia et al. Jan 1987 A
4637406 Guinn et al. Jan 1987 A
4653513 Dombrowski Mar 1987 A
4661319 Lape Apr 1987 A
4702261 Cornell et al. Oct 1987 A
4711250 Gilbaugh, Jr. et al. Dec 1987 A
4737458 Batz et al. Apr 1988 A
4767415 Duffy Aug 1988 A
4774192 Terminiello et al. Sep 1988 A
4787398 Garcia et al. Nov 1988 A
4790979 Terminiello et al. Dec 1988 A
4794926 Munsch et al. Jan 1989 A
4815843 Tiefenthaler et al. Mar 1989 A
4829470 Wang May 1989 A
4844095 Chiodo et al. Jul 1989 A
4846785 Cassou et al. Jul 1989 A
4887306 Hwang et al. Dec 1989 A
4920977 Haynes May 1990 A
4929426 Bodai et al. May 1990 A
4930525 Palestrant Jun 1990 A
4935346 Phillips Jun 1990 A
4953552 De Marzo Sep 1990 A
4966646 Zdeblick Oct 1990 A
4983178 Schnell Jan 1991 A
4995402 Smith Feb 1991 A
5029583 Meserol Jul 1991 A
5035704 Lambert et al. Jul 1991 A
5049487 Phillips et al. Sep 1991 A
5050617 Columbus et al. Sep 1991 A
5059394 Phillips et al. Oct 1991 A
5077199 Basagni et al. Dec 1991 A
5094943 Siedel et al. Mar 1992 A
5110724 Hewett May 1992 A
5114350 Hewett May 1992 A
5116759 Klainer et al. May 1992 A
5131404 Neeley et al. Jul 1992 A
5141868 Shanks et al. Aug 1992 A
5145565 Kater et al. Sep 1992 A
5146437 Boucheron Sep 1992 A
5153416 Neeley Oct 1992 A
5164575 Neeley et al. Nov 1992 A
5166498 Neeley Nov 1992 A
5174291 Schoonen et al. Dec 1992 A
5176632 Bernardi Jan 1993 A
5179005 Phillips et al. Jan 1993 A
5183741 Arai et al. Feb 1993 A
5196302 Kidwell Mar 1993 A
5208163 Charlton et al. May 1993 A
5213966 Vuorinen et al. May 1993 A
5217480 Habar et al. Jun 1993 A
5218966 Yamasawa Jun 1993 A
5223219 Subramanian et al. Jun 1993 A
5228972 Osaka et al. Jul 1993 A
5234818 Zimmermann et al. Aug 1993 A
5241969 Carson et al. Sep 1993 A
5251126 Kahn et al. Oct 1993 A
D341848 Bigelow et al. Nov 1993 S
5269800 Davis, Jr. Dec 1993 A
5275159 Griebel Jan 1994 A
5278079 Gubinski et al. Jan 1994 A
5279294 Anderson et al. Jan 1994 A
5288646 Lundsgaard et al. Feb 1994 A
5299571 Mastrototaro Apr 1994 A
5301686 Newman Apr 1994 A
5302513 Mike et al. Apr 1994 A
5304468 Phillips et al. Apr 1994 A
5306623 Kiser et al. Apr 1994 A
5308767 Terashima May 1994 A
5314441 Cusack et al. May 1994 A
5320607 Ishibashi Jun 1994 A
5354537 Moreno Oct 1994 A
5360595 Bell et al. Nov 1994 A
5368047 Suzuki et al. Nov 1994 A
5383512 Jarvis Jan 1995 A
5390671 Lord et al. Feb 1995 A
5395388 Schraga Mar 1995 A
5399316 Yamada Mar 1995 A
5401110 Neeley Mar 1995 A
5402798 Swierczek et al. Apr 1995 A
5426032 Phillips et al. Jun 1995 A
5441513 Roth Aug 1995 A
5451350 Macho et al. Sep 1995 A
5458140 Eppstein et al. Oct 1995 A
5460777 Kitajima et al. Oct 1995 A
5460968 Yoshida et al. Oct 1995 A
5482473 Lord et al. Jan 1996 A
5506200 Hirschkoff et al. Apr 1996 A
5507288 Böcker et al. Apr 1996 A
5508200 Tiffany et al. Apr 1996 A
5510266 Bonner et al. Apr 1996 A
5514152 Smith May 1996 A
5525518 Lundsgaard et al. Jun 1996 A
5527892 Borsotti et al. Jun 1996 A
5563042 Phillips et al. Oct 1996 A
5568806 Cheney, II et al. Oct 1996 A
5569287 Tezuka et al. Oct 1996 A
5575403 Charlton et al. Nov 1996 A
5577499 Teves Nov 1996 A
5582184 Erickson et al. Dec 1996 A
5586553 Halili et al. Dec 1996 A
5591139 Lin et al. Jan 1997 A
5593838 Zanzucchi et al. Jan 1997 A
5611809 Marshall et al. Mar 1997 A
5624458 Lipscher Apr 1997 A
5630986 Charlton et al. May 1997 A
5632410 Moulton et al. May 1997 A
5636632 Bommannan et al. Jun 1997 A
5647851 Pokras Jul 1997 A
5658515 Lee et al. Aug 1997 A
5660791 Brenneman Aug 1997 A
5670031 Hintsche et al. Sep 1997 A
5676850 Reed et al. Oct 1997 A
5680858 Hansen et al. Oct 1997 A
5681484 Zanzucchi et al. Oct 1997 A
5682233 Brinda Oct 1997 A
5697901 Eriksson Dec 1997 A
5700695 Yassinzadeh et al. Dec 1997 A
5701181 Boiarski et al. Dec 1997 A
5701910 Powles et al. Dec 1997 A
D389761 Thomas Jan 1998 S
5705018 Hartley Jan 1998 A
5708787 Nakano et al. Jan 1998 A
5715417 Gardien et al. Feb 1998 A
5730753 Morita Mar 1998 A
5735273 Kurnik et al. Apr 1998 A
5736103 Pugh Apr 1998 A
5741211 Renirie et al. Apr 1998 A
5746217 Erickson et al. May 1998 A
5746720 Stouder, Jr. May 1998 A
5757666 Schreiber et al. May 1998 A
5759364 Charlton et al. Jun 1998 A
5766066 Ranniger Jun 1998 A
5771890 Tamada Jun 1998 A
5797693 Jaeger Aug 1998 A
5800420 Gross et al. Sep 1998 A
5801057 Smart et al. Sep 1998 A
5807375 Gross et al. Sep 1998 A
5820570 Erickson et al. Oct 1998 A
5827183 Kurnik et al. Oct 1998 A
5840020 Heinonen et al. Nov 1998 A
5841126 Fossum et al. Nov 1998 A
5843692 Phillips et al. Dec 1998 A
5846837 Thym et al. Dec 1998 A
5851215 Mawhirt et al. Dec 1998 A
5854074 Charlton et al. Dec 1998 A
403975 Douglas et al. Jan 1999 A
5855801 Lin et al. Jan 1999 A
5856195 Charlton et al. Jan 1999 A
5858194 Bell Jan 1999 A
5866281 Guckel et al. Feb 1999 A
5871494 Simons et al. Feb 1999 A
5879310 Sopp et al. Mar 1999 A
5879326 Godshall et al. Mar 1999 A
5879367 Latterell et al. Mar 1999 A
5885839 Lingane et al. Mar 1999 A
5891053 Sesekura Apr 1999 A
5893870 Talen et al. Apr 1999 A
D411621 Eisenbarth et al. Jun 1999 S
5911711 Pelkey Jun 1999 A
5911737 Lee et al. Jun 1999 A
5912139 Iwata et al. Jun 1999 A
5925021 Castellano et al. Jul 1999 A
5928207 Pisano et al. Jul 1999 A
5930873 Wyser Aug 1999 A
5938679 Freeman et al. Aug 1999 A
5945678 Yanagisawa Aug 1999 A
5951492 Douglas et al. Sep 1999 A
5951493 Douglas et al. Sep 1999 A
5951521 Mastrototaro et al. Sep 1999 A
5954685 Tierney Sep 1999 A
5962215 Douglas et al. Oct 1999 A
5968760 Phillips et al. Oct 1999 A
5968765 Grage et al. Oct 1999 A
5968836 Matzinger et al. Oct 1999 A
5971941 Simons et al. Oct 1999 A
5972294 Smith et al. Oct 1999 A
5986754 Harding Nov 1999 A
5989409 Kurnik et al. Nov 1999 A
5993189 Mueller et al. Nov 1999 A
D417504 Love et al. Dec 1999 S
6001067 Shults et al. Dec 1999 A
6005545 Nishida et al. Dec 1999 A
6010463 Lauks et al. Jan 2000 A
6010519 Mawhirt et al. Jan 2000 A
6014135 Fernandes Jan 2000 A
6014577 Henning et al. Jan 2000 A
6023629 Tamada Feb 2000 A
6027459 Shain et al. Feb 2000 A
6030827 Davis et al. Feb 2000 A
6032059 Henning et al. Feb 2000 A
6036924 Simons et al. Mar 2000 A
6041253 Kost et al. Mar 2000 A
6045753 Loewy et al. Apr 2000 A
6048352 Douglas et al. Apr 2000 A
6050988 Zuck Apr 2000 A
6056701 Duchon et al. May 2000 A
6056734 Jacobsen et al. May 2000 A
6058321 Swayze et al. May 2000 A
6059815 Lee et al. May 2000 A
6061128 Zweig et al. May 2000 A
6063039 Cunningham et al. May 2000 A
6071251 Cunningham et al. Jun 2000 A
6071294 Simons et al. Jun 2000 A
6077660 Wong et al. Jun 2000 A
6080116 Erickson et al. Jun 2000 A
6083196 Trautman et al. Jul 2000 A
6086544 Hibner et al. Jul 2000 A
6090790 Eriksson Jul 2000 A
6091975 Daddona et al. Jul 2000 A
6093156 Cunningham et al. Jul 2000 A
6097831 Wieck et al. Aug 2000 A
6099484 Douglas et al. Aug 2000 A
6100107 Lei et al. Aug 2000 A
6102933 Lee et al. Aug 2000 A
6103033 Say et al. Aug 2000 A
6103197 Werner Aug 2000 A
6106751 Talbot et al. Aug 2000 A
6118126 Zanzucchi Sep 2000 A
6120676 Heller et al. Sep 2000 A
6123861 Santini, Jr. et al. Sep 2000 A
6126899 Woudenberg et al. Oct 2000 A
6132449 Lum et al. Oct 2000 A
6139562 Mauze et al. Oct 2000 A
6142939 Eppstein et al. Nov 2000 A
6152942 Brenneman et al. Nov 2000 A
6162639 Douglas Dec 2000 A
6172743 Kley et al. Jan 2001 B1
6175752 Say et al. Jan 2001 B1
6176865 Mauze et al. Jan 2001 B1
6183434 Eppstein et al. Feb 2001 B1
6183489 Douglas et al. Feb 2001 B1
6187210 Lebouiz et al. Feb 2001 B1
6192891 Gravel et al. Feb 2001 B1
6193873 Ohara et al. Feb 2001 B1
6200296 Dibiasi et al. Mar 2001 B1
6206841 Cunningham et al. Mar 2001 B1
6214626 Meller et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6228100 Schraga May 2001 B1
6230051 Cormier et al. May 2001 B1
6231531 Lum et al. May 2001 B1
6241862 McAleer et al. Jun 2001 B1
6242207 Douglas et al. Jun 2001 B1
6245215 Douglas et al. Jun 2001 B1
6251083 Yum et al. Jun 2001 B1
6251260 Heller et al. Jun 2001 B1
6254586 Mann et al. Jul 2001 B1
6255061 Mori et al. Jul 2001 B1
6256533 Yuzhakov et al. Jul 2001 B1
6268162 Phillips et al. Jul 2001 B1
6271045 Douglas et al. Aug 2001 B1
6272364 Kurnik Aug 2001 B1
6283926 Cunningham et al. Sep 2001 B1
6289230 Chaiken et al. Sep 2001 B1
6298254 Tamada Oct 2001 B2
6299578 Kurnik et al. Oct 2001 B1
6299757 Feldman et al. Oct 2001 B1
6306104 Cunningham et al. Oct 2001 B1
6309351 Kurnik et al. Oct 2001 B1
D450711 Istvan et al. Nov 2001 S
6312612 Sherman et al. Nov 2001 B1
6312812 Sherman et al. Nov 2001 B1
6312888 Wong et al. Nov 2001 B1
6315738 Nishikawa et al. Nov 2001 B1
6322808 Trautman et al. Nov 2001 B1
6329161 Heller et al. Dec 2001 B1
6331266 Powell et al. Dec 2001 B1
6332871 Douglas et al. Dec 2001 B1
6334856 Allen et al. Jan 2002 B1
6350273 Minagawa et al. Feb 2002 B1
6352514 Douglas et al. Mar 2002 B1
6356776 Berner et al. Mar 2002 B1
6358265 Thorne, Jr. et al. Mar 2002 B1
6364890 Lum et al. Apr 2002 B1
6375626 Allen et al. Apr 2002 B1
6375627 Mauze et al. Apr 2002 B1
6379969 Mauze et al. Apr 2002 B1
6391005 Lum et al. May 2002 B1
6391645 Huang et al. May 2002 B1
6402704 McMorrow Jun 2002 B1
6409679 Pyo Jun 2002 B2
6428664 BhulLar et al. Aug 2002 B1
6449608 Morita et al. Sep 2002 B1
6455324 Douglas Sep 2002 B1
6493069 Nagashimada Dec 2002 B1
6500134 Cassone Dec 2002 B1
6520973 McGarry Feb 2003 B1
6530892 Kelly Mar 2003 B1
6537243 Henning et al. Mar 2003 B1
6540675 Aceti et al. Apr 2003 B2
6544475 Douglas et al. Apr 2003 B1
6549796 Sohrab Apr 2003 B2
6555061 Leong et al. Apr 2003 B1
6558624 Lemmon et al. May 2003 B1
6579690 Bonnecaze et al. Jun 2003 B1
6589260 Schmelzeisen-Redeker et al. Jul 2003 B1
6591125 Buse et al. Jul 2003 B1
6602205 Erickson et al. Aug 2003 B1
6612111 Hodges et al. Sep 2003 B1
6616616 Fritz et al. Sep 2003 B2
6626874 Duchamp Sep 2003 B1
6656167 Numao et al. Dec 2003 B2
6679852 Schmelzeisen-Redeker et al. Jan 2004 B1
6706000 Perez et al. Mar 2004 B2
6706049 Moerman Mar 2004 B2
6706159 Moerman et al. Mar 2004 B2
6740800 Cunningham May 2004 B1
6743635 Neel et al. Jun 2004 B2
6748275 Lattner et al. Jun 2004 B2
6753187 Cizdziel et al. Jun 2004 B2
6766817 da Silva Jul 2004 B2
6793633 Douglas et al. Sep 2004 B2
6830669 Miyazaki et al. Dec 2004 B2
6836678 Tu Dec 2004 B2
6837858 Cunningham et al. Jan 2005 B2
6847451 Pugh Jan 2005 B2
6849052 Uchigaki et al. Feb 2005 B2
6896850 Subramanian et al. May 2005 B2
6918404 Da Silva Jul 2005 B2
6919960 Hansen et al. Jul 2005 B2
6923764 Aceti et al. Aug 2005 B2
6936476 Anderson et al. Aug 2005 B1
511214 Sasano et al. Nov 2005 A1
6988996 Roe et al. Jan 2006 B2
7004928 Aceti et al. Feb 2006 B2
7011630 Desai et al. Mar 2006 B2
7025774 Freeman et al. Apr 2006 B2
D519868 Sasano et al. May 2006 S
7052652 Zanzucchi et al. May 2006 B2
7066586 Da Silva Jun 2006 B2
7066890 Lam et al. Jun 2006 B1
7141058 Briggs et al. Nov 2006 B2
7156809 Quy Jan 2007 B2
7163616 Vreeke et al. Jan 2007 B2
7192061 Martin Mar 2007 B2
D540343 Cummins Apr 2007 S
7223365 Von Der Goltz May 2007 B2
7225008 Ward et al. May 2007 B1
7226461 Boecker et al. Jun 2007 B2
7258673 Racchini et al. Aug 2007 B2
D551243 Young Sep 2007 S
7270970 Anderson et al. Sep 2007 B2
7297151 Boecker et al. Nov 2007 B2
7299081 Mace et al. Nov 2007 B2
7343188 Sohrab Mar 2008 B2
7344507 Briggs et al. Mar 2008 B2
7379167 Mawhirt et al. May 2008 B2
7427377 Zanzucchi et al. Sep 2008 B2
D580068 Shigesada et al. Nov 2008 S
D580558 Shigesada et al. Nov 2008 S
D599373 Kobayashi et al. Sep 2009 S
D601257 Berlinger Sep 2009 S
7585278 Aceti et al. Sep 2009 B2
D601444 Jones et al. Oct 2009 S
D601578 Poulet et al. Oct 2009 S
7682318 Alden et al. Mar 2010 B2
D622393 Gatrall et al. Aug 2010 S
7780631 Lum et al. Aug 2010 B2
7803123 Perez et al. Sep 2010 B2
7879058 Ikeda Feb 2011 B2
7887494 Emery et al. Feb 2011 B2
D642191 Barnett et al. Jul 2011 S
7988644 Freeman et al. Aug 2011 B2
8012103 Escutia et al. Sep 2011 B2
8012104 Escutia et al. Sep 2011 B2
8105849 McDevitt et al. Jan 2012 B2
D654926 Lipman et al. Feb 2012 S
8173439 Petrich et al. May 2012 B2
8184273 Dosmann et al. May 2012 B2
8231832 Zanzucchi et al. Jul 2012 B2
8251920 Vreeke et al. Aug 2012 B2
8298255 Conway et al. Oct 2012 B2
8303518 Aceti et al. Nov 2012 B2
8360993 Escutia et al. Jan 2013 B2
8360994 Escutia et al. Jan 2013 B2
8372015 Escutia et al. Feb 2013 B2
8376959 Deck Feb 2013 B2
8382681 Escutia et al. Feb 2013 B2
8391940 Matzinger et al. Mar 2013 B2
D691174 Lipman et al. Oct 2013 S
8574168 Freeman et al. Nov 2013 B2
8702624 Alden Apr 2014 B2
8795201 Escutia et al. Aug 2014 B2
8801631 Escutia et al. Aug 2014 B2
8919605 Lipman et al. Dec 2014 B2
8969097 Emery et al. Mar 2015 B2
9060723 Escutia et al. Jun 2015 B2
9060727 Saikley et al. Jun 2015 B2
9095292 Zanzucchi et al. Aug 2015 B2
9149215 Werner et al. Oct 2015 B2
9366636 Emery et al. Jun 2016 B2
9380974 Litherland et al. Jul 2016 B2
20010001034 Douglas May 2001 A1
20010027277 Klitmose Oct 2001 A1
20010027328 Lum et al. Oct 2001 A1
20010053891 Ackley Dec 2001 A1
20020002326 Causey, III et al. Jan 2002 A1
20020002344 Douglas et al. Jan 2002 A1
20020004640 Conn et al. Jan 2002 A1
20020006355 Whitson Jan 2002 A1
20020016568 Lebel et al. Feb 2002 A1
20020020688 Sherman et al. Feb 2002 A1
20020022934 Vogel et al. Feb 2002 A1
20020023852 Mcivor et al. Feb 2002 A1
20020042594 Lum et al. Apr 2002 A1
20020052618 Haar et al. May 2002 A1
20020087056 Aceti et al. Jul 2002 A1
20020136667 Subramanian et al. Sep 2002 A1
20020137998 Smart et al. Sep 2002 A1
20020160520 Orloff et al. Oct 2002 A1
20020168290 Yuzhakov et al. Nov 2002 A1
20020169394 Eppstein et al. Nov 2002 A1
20020169411 Sherman et al. Nov 2002 A1
20020177761 Orloff et al. Nov 2002 A1
20020177764 Sohrab Nov 2002 A1
20020183102 Withers et al. Dec 2002 A1
20020188223 Perez et al. Dec 2002 A1
20020198444 Uchigaki et al. Dec 2002 A1
20030012693 Otillar et al. Jan 2003 A1
20030028087 Yuzhakov et al. Feb 2003 A1
20030028125 Yuzhakov et al. Feb 2003 A1
20030039587 Niermann Feb 2003 A1
20030083685 Freeman et al. May 2003 A1
20030083686 Freeman et al. May 2003 A1
20030105961 Zatloukal et al. Jun 2003 A1
20030116596 Terasawa Jun 2003 A1
20030135166 Gonnelli Jul 2003 A1
20030135333 Aceti Jul 2003 A1
20030143746 Sage Jul 2003 A1
20030153844 Smith et al. Aug 2003 A1
20030153900 Aceti et al. Aug 2003 A1
20030175987 Verdonk et al. Sep 2003 A1
20030206302 Pugh Nov 2003 A1
20030207441 Eyster et al. Nov 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030211619 Olson et al. Nov 2003 A1
20030212344 Yuzhakov et al. Nov 2003 A1
20030212347 Sohrab Nov 2003 A1
20030216628 Bortz et al. Nov 2003 A1
20040010207 Flaherty et al. Jan 2004 A1
20040030353 Schmelzeisen-redeker et al. Feb 2004 A1
20040039303 Wurster et al. Feb 2004 A1
20040049219 Briggs et al. Mar 2004 A1
20040059256 Perez Mar 2004 A1
20040072357 Stiene et al. Apr 2004 A1
20040073140 Douglas Apr 2004 A1
20040092842 Boecker et al. May 2004 A1
20040092995 Boecker et al. May 2004 A1
20040094432 Neel et al. May 2004 A1
20040096959 Stiene et al. May 2004 A1
20040097796 Berman et al. May 2004 A1
20040098009 Boecker et al. May 2004 A1
20040102803 Boecker et al. May 2004 A1
20040122339 Roe et al. Jun 2004 A1
20040132167 Rule et al. Jul 2004 A1
20040138588 Saikley et al. Jul 2004 A1
20040155084 Brown Aug 2004 A1
20040157339 Burke et al. Aug 2004 A1
20040178218 Schomakers et al. Sep 2004 A1
20040186394 Roe et al. Sep 2004 A1
20040191119 Zanzucchi et al. Sep 2004 A1
20040202576 Aceti et al. Oct 2004 A1
20040230216 LeVaughn et al. Nov 2004 A1
20040236251 Roe et al. Nov 2004 A1
20040238675 Banaszkiewicz et al. Dec 2004 A1
20040242982 Sakata et al. Dec 2004 A1
20040249253 Racchini et al. Dec 2004 A1
20040259180 Burke et al. Dec 2004 A1
20050004494 Perez et al. Jan 2005 A1
20050010134 Douglas et al. Jan 2005 A1
20050015020 LeVaughn et al. Jan 2005 A1
20050027182 Siddiqui et al. Feb 2005 A1
20050038680 McMahon Feb 2005 A1
20050070819 Poux et al. Mar 2005 A1
20050096686 Allen May 2005 A1
20050106713 Phan et al. May 2005 A1
20050109386 Marshall May 2005 A1
20050159678 Taniike et al. Jul 2005 A1
20050187532 Thurau et al. Aug 2005 A1
20050192492 Cho et al. Sep 2005 A1
20050202567 Zanzucchi et al. Sep 2005 A1
20050202733 Yoshimura et al. Sep 2005 A1
20050209518 Sage, Jr. et al. Sep 2005 A1
20050215872 Berner et al. Sep 2005 A1
20050215923 Wiegel Sep 2005 A1
20050245844 Mace et al. Nov 2005 A1
20050255001 Padmaabhan et al. Nov 2005 A1
20050277972 Wong et al. Dec 2005 A1
20060008389 Sacherer et al. Jan 2006 A1
20060036134 Tarassenko et al. Feb 2006 A1
20060052724 Roe Mar 2006 A1
20060064035 Wang et al. Mar 2006 A1
20060094985 Aceti et al. May 2006 A1
20060117616 Jones et al. Jun 2006 A1
20060122536 Haar et al. Jun 2006 A1
20060135873 Karo et al. Jun 2006 A1
20060155317 List Jul 2006 A1
20060161078 Schraga Jul 2006 A1
20060178600 Kennedy et al. Aug 2006 A1
20060189908 Kennedy Aug 2006 A1
20060204399 Freeman et al. Sep 2006 A1
20060229533 Hoenes et al. Oct 2006 A1
20060241517 Fowler et al. Oct 2006 A1
20060257993 Mcdevitt et al. Nov 2006 A1
20060259102 Slatkine Nov 2006 A1
20060281187 Emery et al. Dec 2006 A1
20070016104 Jansen et al. Jan 2007 A1
20070017824 Rippeth et al. Jan 2007 A1
20070033074 Nitzan et al. Feb 2007 A1
20070060842 Alvarez-Icaza et al. Mar 2007 A1
20070078313 Emery et al. Apr 2007 A1
20070078358 Escutia et al. Apr 2007 A1
20070083130 Thomson et al. Apr 2007 A1
20070083131 Escutia et al. Apr 2007 A1
20070093786 Goldsmith et al. Apr 2007 A1
20070112281 Olson May 2007 A1
20070179404 Escutia et al. Aug 2007 A1
20070179405 Emery et al. Aug 2007 A1
20070253531 Okuzawa et al. Nov 2007 A1
20070255181 Alvarez-Icaza et al. Nov 2007 A1
20070255302 Koeppel et al. Nov 2007 A1
20080012701 Kass et al. Jan 2008 A1
20080046831 Imai et al. Feb 2008 A1
20080077048 Escutia et al. Mar 2008 A1
20080139910 Mastrototaro Jun 2008 A1
20080194934 Ray et al. Aug 2008 A1
20080268485 Guarino et al. Oct 2008 A1
20080269625 Halperin et al. Oct 2008 A1
20090054810 Zanzucchi et al. Feb 2009 A1
20090149717 Brauer et al. Jun 2009 A1
20090156923 Power et al. Jun 2009 A1
20090292489 Burke et al. Nov 2009 A1
20090301899 Hodges et al. Dec 2009 A1
20100010374 Escutia et al. Jan 2010 A1
20100021947 Emery et al. Jan 2010 A1
20100021948 Lipman et al. Jan 2010 A1
20100095229 Dixon et al. Apr 2010 A1
20100174211 Frey et al. Jul 2010 A1
20100185120 Sacherer et al. Jul 2010 A1
20100217155 Poux et al. Aug 2010 A1
20100331650 Batman et al. Dec 2010 A1
20110098599 Emery et al. Apr 2011 A1
20110105872 Chickering et al. May 2011 A1
20110201909 Emery et al. Aug 2011 A1
20110294152 Lipman et al. Dec 2011 A1
20120296179 Zanzucchi et al. Nov 2012 A1
20130110516 Abulhaj et al. May 2013 A1
20130158430 Aceti et al. Jun 2013 A1
20130158432 Escutia et al. Jun 2013 A1
20130172698 Reynolds et al. Jul 2013 A1
20130274568 Escutia et al. Oct 2013 A1
20130274579 Richter et al. Oct 2013 A1
20140012116 Okuyama Jan 2014 A1
20140316301 Escutia et al. Oct 2014 A1
20140336480 Escutia et al. Nov 2014 A1
20140376762 Lipman et al. Dec 2014 A1
20150037898 Baldus et al. Feb 2015 A1
20150153351 Lipman et al. Jun 2015 A1
20150212006 Emery et al. Jul 2015 A1
20160038066 Escutia et al. Feb 2016 A1
Foreign Referenced Citations (203)
Number Date Country
2 201 530 Sep 1997 CA
2 513 465 Aug 2004 CA
197 05 091 Feb 1999 DE
199 22 413 Nov 2000 DE
103 02-501 Aug 2004 DE
0 103 426 Mar 1984 EP
0 256 806 Feb 1988 EP
0 396-016 Nov 1990 EP
0 396-016 Nov 1990 EP
0 397 424 Nov 1990 EP
0 762 311 Mar 1997 EP
0 255-338 Feb 1998 EP
0 849 584 Jun 1998 EP
1 266-607 Dec 2002 EP
1 266-607 Dec 2002 EP
1369688 Oct 2003 EP
1 360-934 Nov 2003 EP
1 360-934 Nov 2003 EP
1 486-766 Dec 2004 EP
1 486-766 Dec 2004 EP
1 529-489 May 2005 EP
1 529-489 May 2005 EP
1 769-735 Apr 2007 EP
1 987 766 Nov 2008 EP
63-305841 Dec 1988 JP
3-63570 Mar 1991 JP
03093189 Apr 1991 JP
7-67861 Mar 1995 JP
7-213925 Aug 1995 JP
9-168530 Jun 1997 JP
9-313465 Sep 1997 JP
9-266889 Oct 1997 JP
9-294737 Nov 1997 JP
10-024028 Jan 1998 JP
10-505258 May 1998 JP
10-508518 Aug 1998 JP
10-318970 Dec 1998 JP
11056822 Mar 1999 JP
11281779 Oct 1999 JP
2000-116629 Apr 2000 JP
2000-126161 May 2000 JP
2000-168754 Jun 2000 JP
2000-254111 Sep 2000 JP
2001-159618 Jun 2001 JP
2001-515203 Sep 2001 JP
2001-305096 Oct 2001 JP
2001-330581 Nov 2001 JP
2002-502045 Jan 2002 JP
2002-085384 Mar 2002 JP
2002-514453 May 2002 JP
2002-168862 Jun 2002 JP
2003-507719 Feb 2003 JP
2003-108679 Apr 2003 JP
2003-180417 Jul 2003 JP
2004-000598 Jan 2004 JP
2004-500948 Jan 2004 JP
2004-117339 Apr 2004 JP
2004-202256 Jul 2004 JP
2004-209266 Jul 2004 JP
2004-519302 Jul 2004 JP
2004-522500 Jul 2004 JP
2004-528936 Sep 2004 JP
2005-503538 Feb 2005 JP
2005-087613 Apr 2005 JP
2006-512969 Apr 2005 JP
3638958 Apr 2005 JP
2005-525149 Aug 2005 JP
2005-237938 Sep 2005 JP
2005-525846 Sep 2005 JP
2005-527254 Sep 2005 JP
2006-506185 Feb 2006 JP
2006-512974 Apr 2006 JP
2006-516723 Jul 2006 JP
2006-521555 Sep 2006 JP
2006-527013 Nov 2006 JP
2007-054407 Mar 2007 JP
2007-067698 Mar 2007 JP
2007-521031 Aug 2007 JP
2007-311196 Nov 2007 JP
2007-537804 Dec 2007 JP
2008-125813 Jun 2008 JP
WO-8605966 Oct 1986 WO
WO-8800812 Feb 1988 WO
WO-8807666 Oct 1988 WO
WO-9114212 Sep 1991 WO
WO-9413203 Jun 1994 WO
WO-9510223 Apr 1995 WO
WO-9510223 Apr 1995 WO
WO-9604857 Feb 1996 WO
WO-9607907 Mar 1996 WO
WO-9614026 May 1996 WO
WO-9625088 Aug 1996 WO
WO-9715227 May 1997 WO
WO-9729847 Aug 1997 WO
WO-9730344 Aug 1997 WO
WO-9741421 Nov 1997 WO
WO-9742885 Nov 1997 WO
WO-9742888 Nov 1997 WO
WO-9743962 Nov 1997 WO
WO-9800193 Jan 1998 WO
WO-9831275 Jul 1998 WO
WO-9835225 Aug 1998 WO
WO-9912008 Mar 1999 WO
WO-9923492 May 1999 WO
WO-9944508 Sep 1999 WO
WO-9956954 Nov 1999 WO
WO-9958051 Nov 1999 WO
WO-9962576 Dec 1999 WO
WO-0009184 Feb 2000 WO
WO-0013573 Mar 2000 WO
WO-0014269 Mar 2000 WO
WO-0014535 Mar 2000 WO
WO-0018449 Apr 2000 WO
WO-0018449 Apr 2000 WO
WO-0036400 Jun 2000 WO
WO-0042422 Jul 2000 WO
WO-0074763 Dec 2000 WO
WO-0074763 Dec 2000 WO
WO-0078208 Dec 2000 WO
WO-0113795 Mar 2001 WO
WO-0116575 Mar 2001 WO
WO-0152727 Jul 2001 WO
WO-0164105 Sep 2001 WO
WO-0164105 Sep 2001 WO
WO-0172220 Oct 2001 WO
WO-0180728 Nov 2001 WO
WO-0185233 Nov 2001 WO
WO-0185233 Nov 2001 WO
WO-0191634 Dec 2001 WO
WO-0191634 Dec 2001 WO
WO-0200101 Jan 2002 WO
WO-0200101 Jan 2002 WO
WO-0249507 Jun 2002 WO
WO-0249509 Jun 2002 WO
WO-0249509 Jun 2002 WO
WO-02078533 Oct 2002 WO
WO-02078533 Oct 2002 WO
WO-02082052 Oct 2002 WO
WO-02082052 Oct 2002 WO
WO-02093144 Nov 2002 WO
WO-02100251 Dec 2002 WO
WO-02100251 Dec 2002 WO
WO-02101359 Dec 2002 WO
WO-02101359 Dec 2002 WO
WO-03007819 Jan 2003 WO
WO-2003030984 Apr 2003 WO
WO-2003066128 Aug 2003 WO
WO-2003066128 Aug 2003 WO
WO-2003070099 Aug 2003 WO
WO-2003071940 Sep 2003 WO
WO-2003071940 Sep 2003 WO
WO-2004045375 Jun 2004 WO
WO-2004045375 Jun 2004 WO
WO-2004062499 Jul 2004 WO
WO-2004062500 Jul 2004 WO
WO-2004062500 Jul 2004 WO
WO-2004064636 Aug 2004 WO
WO-2004085995 Oct 2004 WO
WO-2004085995 Oct 2004 WO
WO-2004091693 Oct 2004 WO
WO-2004091693 Oct 2004 WO
WO-2004105827 Dec 2004 WO
WO-2004105827 Dec 2004 WO
WO-2005006939 Jan 2005 WO
WO-2005006939 Jan 2005 WO
WO-2005009238 Feb 2005 WO
WO-2005013824 Feb 2005 WO
WO-2005018709 Mar 2005 WO
WO-2005018709 Mar 2005 WO
WO-2005018710 Mar 2005 WO
WO-2005018710 Mar 2005 WO
WO-2005084543 Sep 2005 WO
WO-2005084546 Sep 2005 WO
WO-2005084546 Sep 2005 WO
WO-2005085995 Sep 2005 WO
WO-2005112763 Dec 2005 WO
WO-2006138226 Dec 2006 WO
WO-2006138226 Dec 2006 WO
WO-2007041062 Apr 2007 WO
WO-2007041062 Apr 2007 WO
WO-2007041063 Apr 2007 WO
WO-2007041063 Apr 2007 WO
WO-2007041244 Apr 2007 WO
WO-2007041244 Apr 2007 WO
WO-2007041287 Apr 2007 WO
WO-2007041287 Apr 2007 WO
WO-2007041355 Apr 2007 WO
WO-2007041355 Apr 2007 WO
WO-2007108519 Sep 2007 WO
WO-2007112034 Oct 2007 WO
WO-2007112034 Oct 2007 WO
WO-2007131036 Nov 2007 WO
WO-2008027319 Mar 2008 WO
WO-2008027319 Mar 2008 WO
WO-2008062648 May 2008 WO
WO-2009145920 Dec 2009 WO
WO-2009148624 Dec 2009 WO
WO-2009148626 Dec 2009 WO
WO-2011065981 Jun 2011 WO
WO-2011162823 Dec 2011 WO
WO-2012127870 Sep 2012 WO
WO-2013020103 Feb 2013 WO
WO-2014205412 Dec 2014 WO
Non-Patent Literature Citations (169)
Entry
ADA Consensus Development Panel. (Jan.-Feb. 1987). “Consensus Statement on Self-Monitoring of Blood Glucose,” Diabetes Care 10(1):95-99.
ADA (Jan. 1994). “Self-Monitoring of Blood Glucose,” Consensus Statement Diabetes Care 17(1):81-86.
Anonymous. (Sep. 30, 1993). “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.” The New England Journal of Medicine 329(14):977-986.
Anonymous. (Jun. 23, 1998). Taking the “Ouch” Out of Needles: Arrays of “Microneedles” Offer New Techniques for Drug Delivery, Science Daily, located at <http:www.sciencedaily.com/releases/1998/06/980623045850.htm>, last visited Jan. 14, 2014, 3 pages.
Beregszàszi, M. et al. (Jul. 1997). “Nocturnal Hypoglycemia in Children and Adolescents with Insulin-Dependent Diabetes Mellitus: Prevalence and Risk Factors,” J. Pediatrics 131(1 Pt. 1):27-33.
Chase, H.P. et al. (Feb. 2001). “Continuous Subcutaneous Glucose Monitoring in Children with Type 1 Diabetes,” Pediatrics 107(2):222-226.
Clarke, W.L. et al. (Sep.-Oct. 1987). “Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,” Diabetes Care 10(5):622-628.
Collison, M.E. et al. (Sep. 1999). “Analytical Characterization of Electrochemical Biosensor Test Strips for Measurement of Glucose in Low-Volume Interstitial Fluid Samples,” Clinical Chemistry 45(9):1665-1673.
Coster, S. et al. (2000). “Monitoring Blood Glucose Control in Diabetes Mellitus: a Systematic Review.” Health Technology Assessment 4(12):1-93.
Cox, D.J. et al. (Jun. 1997). “Understanding Error Grid Analysis,” Diabetes Care 20(6):911-912.
D'Arrigo, T.D. (Mar. 2000). “GlucoWatch Monitor Poised for Approval,” Diabetes Forecast, 53(3):43-44.
Feldman, B. et al. (2000). “FreeStyle™: A Small-Volume Electrochemical Glucose Sensor for Home Blood Glucose Testing,” Diabetes Technology and Therapeutics, 2(2):221-229.
Johnson, R.N. et al. (Jan. 1998). “Accuracy of Devices Used for Self-Monitoring of Blood Glucose,” Annals of Clinical Biochemistry 35(1):68-74.
Johnson, R.N. et al. (Jan. 1999). “Analytical Error of Home Glucose Monitors: A Comparison of 18 Systems,” Annals of Clinical Biochemistry 36(1):72-79.
Johnson, R.N. et al. (2001). “Error Detection and Measurement in Glucose Monitors,” Clinica Chimica Acta 307:61-67.
Kumetrix, Inc. (Dec. 1999). “Painless Blood Glucose Monitoring, Courtesy of the Mosquito,” Start-Up pp. 27-28.
Lee, S-C. (Jun. 1999). “Light Scattering by Closely Spaced Parallel Cylinders Embedded in a Finite Dielectric Slab,” Journal of the Optical Society of America A 16(6):1350-1361.
McGarraugh, G. et al. (2001). “Physiological Influences on Off-Finger Glucose Testing,” Diabetes Technology & Therapeutics 3(3):367-376.
McNichols, R.J. et al. (Jan. 2000). “Optical Glucose Sensing in Biological Fluids: An Overview,” Journal of Biomedical Optics, 5(1):5-16.
Mahler, R.J. et al. (1999). “Clinical Review 102, Type 2 Diabetes Melitus: Update on Diagnosis Pathophysiology, and Treatment,” The Journal of Clinical Endocrinology and Metabolism 84(4):1165-1171.
Medline Plus. (Jun. 17, 2008). , Medical Encyclopedia, Monitor Blood Glucose-Series: Part 1-4, 6 pages.
Neeley, W.E. et al. (1981). “An Instrument for Digital Matrix Photometry,” Clinical Chemistry 27(10):1665-1668.
Neeley, W.E. (1983). “Reflectance Digital Matrix Photometry,” Clinical Chemistry 29(6):1038-1041.
Neeley, W.E. (1983). “Multilayer Film Analysis for Glucose in 1-μL Samples of Plasma,” Clinical Chemistry 29(12):2103-2105.
Neeley, W.E. (1988). “A Reflectance Photometer with a Square Photodiode Array Detector for Use on Multilayer Dry-Film Slides,” Clinical Chemistry 34(11):2367-2370.
Otto, E. et al. (2000). “An Intelligent Diabetes Software Prototype: Predicting Blood Glucose Levels and Recommending Regimen Changes,” Diabetes Technology and Therapeutics 2(4):569-576.
Pfohl, M. et al. (2000). “Spot Glucose Measurement in Epidermal Interstitial Fluid—An Alternative to Capillary Blood Glucose Estimation,” Experimental and Clinical Endocrinology & Diabetes 108(1):1-4.
Princen, H.M. (May 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, I. Capillary Rise Between Two Cylinders,” Journal of Colloid and Interface Science 30(1):69-75.
Princen, H.M. (Jul. 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, II. Capillary Rise in Systems with More Than Two Cylinders,” Journal of Colloid and Interface Science 30(3):359-371.
Rebrin, K. et al. (Sep. 1999). “Subcutaneous Glucose Predicts Plasma Glucose Independent of Insulin: Implications for Continuous Monitoring,” American Journal of Physiology 277(3):E561-E571.
Rosen, S. (1999). “Road to New-Age Glucose Monitoring Still Rocky,” Diagnostic Insight, pp. 4-5, 12-13, 16.
Smart, W.H. et al. (2000). “The Use of Silicon Microfabrication Technology in Painless Glucose Monitoring,” Diabetes Technology & Therapeutics 2(4):549-559.
Svedman, C. et al. (Apr. 1999). “Skin Mini-Erosion Technique for Monitoring Metabolites in Interstitial Fluid: Its Feasibility Demonstrated by OGTT Results in Diabetic and Non-Diabetic Subjects,” Scand. J. Clin. Lab. Invest. 59(2):115-123.
Trinder, P. (1969). “Determination of Glucose in Blood Using Glucose Oxidase with an Alternate Oxygen Acceptor,” Annals of Clinical Biochemistry 6:24-28.
Yum, S. I. et al. (Nov. 1, 1999). “Capillary Blood Sampling for Self-Monitoring of Blood Glucose,” Diabetes Technology & Therapeutics, 1(1):29-37.
Final Office Action dated Mar. 27, 2014, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 10 pages.
International Search Report dated Jul. 28, 2009, for PCT Application No. PCT/US2009/003445, filed on Jun. 8, 2009, 2 pages.
International Search Report dated Nov. 14, 2011, for PCT Application No. PCT/US2011/001132, filed on Jun. 24, 2011, 2 pages.
Non-Final Office Action dated Mar. 2, 2012, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 7 pages.
Non-Final Office Action dated May 30, 2013, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 9 pages.
Written Opinion dated on Jul. 28, 2009, for PCT Application No. PCT/US2009/003445, filed on Jun. 8, 2009, 4 pages.
Written Opinion dated Nov. 14, 2011, for PCT Application No. PCT/US2011/001132, filed on Jun. 24, 2011, 6 pages.
Brazzle, J. et al. Active Microneedles with Integrated Functionality, Solid-State Sensor and Actuator Workshop, Hilton Head Island, South Carolina, Jun. 4-8, 2000, Technical Digest, 199-202.
Burge, M.R., (Aug. 2001). “Lack of Compliance with Home Blood Glucose Monitoring Predicts Hospitalization in Diabetes”, Diabetes Care 24(8): 1502-1503.
Clarke, W.L. et al. (1981). “Evaluation of a New Reflectance Photometer for Use in Home Blood Glucose Monitoring,” Diabetes Care 4(5):547-550.
Extended European Search Report dated Apr. 19, 2011, for EP Application No. 10 18 0848.3 filed Sep. 28, 2010, 5 pages.
Extended European Search Report dated Feb. 22, 2012, for EP Application No. EP 10 18 1155, filed Sep. 28, 2010, 6 pages.
Extended European Search Report dated Jan. 22, 2013, for EP Application No. 12182900.6, filed on Sep. 29, 2006, 6 pages.
Extended European Search Report dated Apr. 29, 2013 for EP Patent Application No. 12192620.8, filed on Nov. 14, 2012, 8 pages.
Extended European Search Report dated Nov. 8, 2016, for EP Application No. 16 167 087.2, filed on Aug. 3, 2012, 6 pages.
Extended European Search Report dated Jun. 16, 2014, for EP Application No. 09758787.7, filed on Jun. 8, 2009, 6 pages.
Extended European Search Report dated Jul. 18, 2013, for EP Application No. 06 772 943.4, filed on Jun. 13, 2006, 7 pages.
Extended European Search Report dated Aug. 27, 2012, for EP Application No. 09 758 789.3, filed on Jun. 8, 2009, 13 pages.
Extended European Search Report dated Oct. 27, 2016, for EP Application No. 11 798 518.4, filed on Jun. 24, 2011, 7 pages.
Extended European Search Report dated Jan. 20, 2017, for EP Application No. 14 813 126.1, filed Jun. 20, 2014, 8 pages.
Final Office Action dated Jul. 9, 2008, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 19 pages.
Final Office Action dated Nov. 23, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 20 pages.
Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 7 pages.
Final Office Action dated Aug. 15, 2013 for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages.
Final Office Action dated Apr. 13, 2016, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 31 pages.
Final Office Action dated Aug. 28, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 11 pages.
Final Office Action dated Dec. 26, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 9 pages.
Final Office Action dated Jan. 22, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages.
Final Office Action dated Jun. 30, 2010, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 11 pages.
Final Office Action dated May 30, 2007, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 11 pages.
Final Office Action dated Nov. 1, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 9 pages.
Final Office Action dated Nov. 21, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages.
Final Office Action dated Jun. 11, 2010, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 16 pages.
Final Office Action dated Mar. 10, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 24 pages.
Final Office Action dated May 8, 2012, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 7 pages.
Final Office Action dated Dec. 26, 2014, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 9 pages.
Final Office Action dated May 5, 2016, for U.S. Appl. No. 14/311,114, filed Jun. 20, 2014, 13 pages.
Final Office Action dated May 5, 2016, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 11 pages.
Final Office Action dated Oct. 15, 2009, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 13 pages.
Final Office Action dated Aug. 14, 2012, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Final Office Action dated Sep. 23, 2013, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Hemmerich, K.J. et al. (Apr. 1995).“Guide to Engineering Thermoplastics,” Medical Devices and Diagnostic Industry pp. 39-59.
International Search Report dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 3 pages.
International Search Report dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 1 page.
International Search Report dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 1 page.
International Search Report dated on Aug. 17, 2007 for PCT/US2006/38049, filed on Sep. 29, 2006, 1 page.
International Search Report dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 4 pages.
International Search Report dated Oct. 15, 2014 for PCT Application No. PCT/US2014/043516, filed on Jun. 20, 2014, 2 pages.
International Search Report dated Jan. 16, 2008, for PCT Application No. PCT/US2006/022840, filed on Jun. 13, 2006, 1 page.
Integ. (2000). “LifeGuide™ Glucose Meter. No Lancets. No Blood,” located at <http://www.integonline.com>, last visited May 1, 2000, 10 pages.
Ishii H. et al., (Aug. 2001). “Seasonal Variation of Glycemic Control in Type 2 Diabetic Patients”, Diabetes Care 24(8):1503.
Massey V. et al. (Aug. 1960). “Studies on the Reaction Mechanism of Lipoyl Dehydrogenase” Biochim. Biophys. Acta 48: 33-47.
Non-Final Office Action dated Dec. 12, 2007, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 13 pages.
Non-Final Office Action dated Apr. 28, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 21 pages.
Non-Final Office Action dated Jun. 4, 2010, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 23 pages.
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,592, filed Aug. 3, 2011, 7 pages.
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,603, filed Aug. 3, 2011, 6 pages.
Non-Final Office Action dated Nov. 26, 2012 for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 9 pages.
Non Final Office Action dated Apr. 8, 2015, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 11 pages.
Non Final Office Action dated Apr. 12, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 7 pages.
Non Final Office Action dated Aug. 5, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages.
Non Final Office Action dated Dec. 5, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages.
Non Final Office Action dated Jan. 12, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages.
Non Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages.
Non Final Office Action dated Jul. 13, 2010, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 11 pages.
Non Final Office Action dated Jul. 31, 2015, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 16 pages.
Non Final Office Action dated Mar. 21, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages.
Non Final Office Action dated Mar. 25, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 13 pages.
Non Final Office Action dated Mar. 5, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages.
Non Final Office Action dated May 14, 2008, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages.
Non Final Office Action dated May 16, 2013, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages.
Non Final Office Action dated May 5, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 8 pages.
Non Final Office Action dated Nov. 2, 2006, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 10 pages.
Non Final Office Action dated Oct. 14, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 10 pages.
Non Final Office Action dated Oct. 3, 2008, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 10 pages.
Non-Final Office Action dated Dec. 17, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 6 pages.
Non Final Office Action dated Dec. 2, 2004, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 8 pages.
Non-Final Office Action dated Jan. 27, 2009, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages.
Non-Final Office Action dated Jan. 6, 2014, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages.
Non-Final Office Action dated Jun. 21, 2013, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 12 pages.
Non-Final Office Action dated Jun. 6, 2008, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages.
Non-Final Office Action dated Oct. 9, 2014, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 15 pages.
Non-Final Office Action dated Sep. 29, 2004, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages.
Non-Final Office Action dated Nov. 23, 2011, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 6 pages.
Written Opinion dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 7 pages.
Non-Final Office Action dated Jun. 25, 2015, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 7 pages.
Non-Final Office Action dated Jul. 8, 2015, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 13 pages.
Non-Final Office Action dated Aug. 19, 2015, for U.S. Appl. No. 14/311,114, filed Jun. 20, 2014, 15 pages.
Non-Final Office Action dated Mar. 19, 2009, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 15 pages.
Non-Final Office Action dated Sep. 1, 2010, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 15 pages.
Non-Final Office Action dated Sep. 13, 2011, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Non-Final Office Action dated Feb. 28, 2013, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 12 pages.
Non-Final Office Action dated Apr. 10, 2014, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Non-Final Office Action dated May 29, 2015, for U.S. Appl. No. 14/614,177, filed Feb. 4, 2015, 13 pages.
Notice of Allowance dated May 3, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 12 pages.
Notice of Allowance dated Mar. 27, 2015, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages.
Notice of Allowance dated Apr. 18, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages.
Notice of Allowance dated Apr. 19, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages.
Notice of Allowance dated Aug. 3, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages.
Notice of Allowance dated Jan. 14, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages.
Notice of Allowance dated Jun. 29, 2012, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 5 pages.
Notice of Allowance dated Mar. 14, 2012, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages.
Notice of Allowance dated Mar. 31, 2005, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages.
Notice of Allowance dated May 15, 2008, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 7 pages.
Notice of Allowance dated May 18, 2009, for U.S. Appl. No. 29/300,934, filed May 30, 2008, 4 pages.
Notice of Allowance dated May 28, 2009, for U.S. Appl. No. 29/300,933, filed May 30, 2008, 6 pages.
Notice of Allowance dated Nov. 23, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages.
Notice of Allowance dated Nov. 27, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages.
Notice of Allowance dated Nov. 29, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 6 pages.
Notice of Allowance dated Oct. 12, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages.
Notice of Allowance dated Feb. 23, 2015, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 8 pages.
Notice of Allowance dated Feb. 5, 2014, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 9 pages.
Notice of Allowance dated Jun. 15, 2009, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 6 pages.
Notice of Allowance dated Mar. 2, 2016, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages.
Notice of Allowance dated Mar. 28, 2005, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 6 pages.
Notice of Allowance dated Jan. 26, 2017, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 7 pages.
Notice of Allowance dated Sep. 18, 2014, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 9 pages.
Notice of Allowance dated Feb. 16, 2016, for U.S. Appl. No. 14/614,177, filed Feb. 4, 2015, 7 pages.
Restriction Requirement dated Sep. 29, 2011, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 6 pages.
Restriction Requirement dated Dec. 22, 2011, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 6 pages.
Restriction Requirement dated Jul. 19, 2011, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 6 pages.
Sonntag, O. (1993). Ektachem. Dry Chemistry, Analysis With Carrier-Bound Reagents, Elsevier Science Publishers, 57 pages.
Spielman, A. et al. (2001). Mosquito: A Natural History of Our Most Persistent and Deadly Foe, First Edition, Hyperion, New York, NY, 3 pages. (Table of Contents Only).
Straub F.B. (Mar., 1939). “Isolation and Properties of a flavoprotien from Heart Muscle Tissue”, Biochemical Journal 33: 787-792.
Tietz, N.W. (1986).Textbook of Clinical Chemistry, W. B. Saunders Company, pp. 1533 and 1556.
U.S. Precision Lens, Inc. (1983).The Handbook of Plastic Optics.
Written Opinion dated Jul. 28, 2009, for PCT Application No. PCT/US2009/003441, filed on Jun. 8, 2009, 10 pages.
Written Opinion dated Oct. 15, 2014 for PCT Application No. PCT/US2014/043516, filed on Jun. 20, 2014, 5 pages.
Written Opinion of the International Searching Authority dated Jan. 16, 2008, for PCT Application No. PCT/US2006/022840, filed on Jun. 13, 2006, 3 pages.
Written Opinion dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 4 pages.
Written Opinion dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 5 pages.
Written Opinion dated Aug. 17, 2007 for PCT/US06/38049, filed Sep. 29, 2006, 6 pages.
Written Opinion dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 4 pages.
Final Office Action dated Jan. 20, 2016, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 10 pages.
Related Publications (1)
Number Date Country
20120166090 A1 Jun 2012 US
Provisional Applications (1)
Number Date Country
61358825 Jun 2010 US